Overview
- AbbVie, which announced the plan Wednesday, will invest $1.4 billion to develop a 185-acre campus near Research Triangle Park to make sterile injectable drugs.
- The company plans 734 permanent hires over four years at an average salary near $118,000, plus more than 2,000 construction jobs during the build.
- Construction is slated to start in 2026 with full buildout targeted for late 2028.
- North Carolina approved incentives that pay out only after results, with reports ranging from a $19.3 million JDIG to about $26 million in state support and local grants that could bring the package near $50.8 million.
- The site will be AbbVie’s U.S. center for small-volume injectable medicines and will use AI and advanced manufacturing, which the company frames as part of a broader $100 billion U.S. investment push.